NuvOx licenses stroke emulsion treatment from U. of Arkansas; Hovione files IND for topical acne med;

> NuvOx Pharma snagged an exclusive license from the University of Arkansas for a dodecafluoropentane emulsion that can reduce brain damage from stroke by over 80%. Release

> Hovione filed an investigational new drug application with the FDA for its minocycline gel, a topical delivery solution for the commonly used acne treatment. It would be the first such topical formulation approved. Release